AZ-UNIVERSAL-ELECTRONICS
22.12.2022 12:06:42 CET | Business Wire | Press release
Universal Electronics Inc. (NASDAQ: UEIC), the worldwide leader in universal control technology for entertainment and smart home devices today announced that it has been named a CES® 2023 Innovation Awards Honoree for its UEI Eterna remote control. This year’s CES Innovation Awards program received a record-high number of over 2100 submissions. The announcement was made ahead of CES 2023, the world’s most influential technology event, happening Jan. 5-8 in Las Vegas, NV.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221222005096/en/
UEI's Eterna Remote Receives the CES 2023 Innovation Award (Graphic: Business Wire)
Maximum performance with minimum battery waste
Targeting TV service providers that want to minimize their carbon footprint and battery waste without compromising on the consumer experience, UEI has designed and developed its most advanced and sustainable voice remote-control platform ever.
The UEI Eterna family of products are built with UEI’s new Xtreme Low-Power Bluetooth LE silicon making them 2.5 times more powerful and up to 10 times more efficient than the previous generation of voice remote controls. In combination with a revolutionary high-density photovoltaic panel that harvests three times more energy than traditional panels, it can self-power despite intense usage or in low light conditions.
For better accessibility in the dark, the UEI Eterna line supports Ambient-Aware backlighting. The backlight activates when there is insufficient lighting in the room. This further reduces power consumption to a bare minimum. UEI Eterna is built with recycled and recyclable materials and packaged free of single-use plastics (SUP). To facilitate refurbishment and recycling programs, the products are specifically designed for easy disassembly which helps to minimize waste and maximize the re-use of field returned units.
“With sustainability as a driving force for product innovation and design at UEI, we are delighted that our UEI Eterna product received this award,” said Menno Koopmans, SVP of Global Sales and Marketing. “The UEI Eterna remote is the first of its kind that delivers on our customers’ sustainability goals without having to compromise on user experience or product features. This innovation is a clear milestone on our journey towards a battery-less world.”
The UEI Eterna and UEI Eterna XLR also feature a unique Interactive Light Bar that communicates its status in real-time with the end user using distinct and recognizable light patterns.
The product line comes with a unique pre-integrated support system that enhances its sustainability performance as it minimizes customer service calls or related truck rolls:
- Powered by QuickSet® Cloud, it supports UEI’s unique and widely adopted automated discovery and set-up capability to pair the set-top-box remote with the customer’s TV, soundbar or audio system. In 2022 alone, QuickSet is estimated to have saved UEI’s existing pay TV customers over 4 million man-hours of programming time.
- It is supported by UEI’s Virtual Agent that provides self-help capabilities during installation, feature discovery and troubleshooting, and is available on both the TV screen and the mobile device.
- It comes with the turnkey white label My Nevo Companion App to enable the setup and support via a mobile device, customize the user preferences, and optimize power management.
- UEI’s new plug-and-play SDK facilitates easy and trouble-free integration with Android TV set-top boxes.
The UEI Eterna family of products is developed for Android TV and RDK operating systems and is scheduled to be available by the end of the first quarter of 2023.
To schedule a press tour or demo please visit here, or come by our booth #52014 at the Venetian Expo at CES taking place in Las Vegas on January 5-8.
About the CES Innovations Award
The CES Innovation Awards program is an annual competition honoring outstanding design and engineering in 28 consumer technology product categories. Those with the highest rating receive the “Best of Innovation” distinction. An elite panel of industry expert judges, including members of the media, designers, engineers and more, reviewed submissions based on innovation, engineering and functionality, aesthetics and design.
About Universal Electronics
Universal Electronics Inc. (NASDAQ:UEIC), Universal Electronics Inc. (NASDAQ: UEIC), the global leader in wireless universal control solutions for home entertainment and smart home devices; designs, develops, manufactures, ships and supports hardware and software control and sensor technology solutions. UEI partners with many Fortune 500 customers, including Comcast, Vivint Smart Home, Samsung, LG, Sony, and Daikin to serve video, telecommunications, security service providers, television, smart home, and HVAC system manufacturers. For over 35 years, UEI has been pioneering breakthrough innovations such as voice control and QuickSet cloud, the world’s leading platform for automated set-up and control of devices in the home. For more information visit www.uei.com
Safe Harbor Statement
This press release contains forward-looking statements that are made pursuant to the Safe-Harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting something other than historical fact are intended to identify forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development, delivery, technical performance, and market acceptance of products and technologies identified in this release; the purchasing by UEI customers of the UEI ETERNA products identified in this release in the quantities anticipated by management; the adoption of the energy harvesting and low power technologies identified in this release by UEI customers, the continued penetration and growth of UEI low power, energy harvesting, and other products and consumer technologies identified in this release; and other factors described in UEI’s filings with the Securities and Exchange Commission. The actual results that UEI achieves may differ materially from any forward-looking statement due to such risks and uncertainties. UEI undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221222005096/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom